GRCE

Conviction 0HealthcareScan · Mon, Aug 10, 2026

GRCE$2.10-1.41%

ResistanceSupportVol 14

Vol MA14 297.02K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Grace Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.gracetx.com ↗

Price2.10

Change-1.41%

Gap-0.94%

Rel volume0.94×

Avg volume251.49K

Avg $ vol551.87K

SMA 202.26

SMA 502.33

SMA 2003.17

Price vs 50-9.75%

Price vs 200-33.65%

MA stackbearish

50/200 cross—

Supertrenddown · 2.49

RSI (14)36

MACD hist-0.01

MACD cross—

Stoch %K / %D42 / 43

ADX (14)17

+DI / −DI15 / 21

RSI divergence—

MACD divergence—

ATR %+6.57%

ADR %5.90%

52w high5.13

52w low2.07

From 52w high-59.06%

Above 52w low+1.45%

New 52w highNo

SqueezeOff

Bollinger width26.14%

%B0.23

Donchian pos36.23%

Donchian high2.54

Donchian low1.85

AVWAP (52w high)2.94

vs AVWAP high-28.46%

AVWAP (52w low)2.41

vs AVWAP low-12.80%

OBV trendDown

Chaikin MF (20)-0.04

Today vs 20d0.94×

Avg vol (14d)297.02K

Avg vol (20d)251.49K

Avg $ vol (20d)551.87K

Market cap34.18M

RS 3m (vs SPY)-11.03%

RS 6m (vs SPY)-52.91%

RS line new highNo

Trend template0/8

Technical rank9.0

1 week+0.96%

1 month-14.29%

3 months-10.26%

6 months-41.67%

1 year-28.81%

YTD-42.62%

P/E-4.39

P/B0.53

P/S0.34

P/FCF-3.72

EPS-0.4700

Div yield—

ROE-12.20%

ROA-11.69%

Debt/Eq—

Current8.10

EV/EBITDA—

Gross margin—

Net margin-7.79%

Rev growth—

EPS growth18.55%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value17.2M

Revenue—

Net income-2.31M

Gross profit—

Free cash flow-9.19M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out15.47M

Employees6

ListedTue, Apr 26, 2011

Free float8.3M

Float %53.7%

Short interest1.63M

Days to cover9.2d

Short volume36.7%

Squeeze score64 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank9.0 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.56

Support1.96

Days since event—

Candle confirm—

News sentiment—

Financials as of Wed, Dec 31, 2025 · quarterly.

Congress activity

Disclosed STOCK Act trades in GRCE

All disclosures →

No recent disclosed trades by Congress in GRCE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GRCE

No recent insider (Form 4) filings in GRCE. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in GRCE · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.